Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | N/A | 11,947 |
| Marketable Securities | N/A | N/A | 7,497 |
| Receivables | N/A | N/A | 454 |
| Inventories | N/A | N/A | 419 |
| Other current assets | 0 | 0 | 163 |
| TOTAL | $N/A | $N/A | $20,480 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 9,868 |
| Other Non-Current Assets | 0 | 0 | 14,350 |
| TOTAL | $N/A | $N/A | $24,218 |
| Total Assets | $N/A | $N/A | $41,878 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | N/A | 3,990 |
| Accounts payable and accrued liabilities | 0 | 0 | 970 |
| Accrued Expenses | N/A | N/A | 1,210 |
| TOTAL | $N/A | $N/A | $6,177 |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | N/A | 16,454 |
| TOTAL | $N/A | $N/A | $19,704 |
| Total Liabilities | $N/A | $N/A | $25,886 |
| Shareholders' Equity | |||
| Common Shares | N/A | N/A | 1 |
| Retained earnings | N/A | N/A | -59,462 |
| Other shareholders' equity | 0 | 0 | 70,843 |
| TOTAL | $N/A | $N/A | $15,992 |
| Total Liabilities And Equity | $0 | $0 | $41,878 |